Home Newsfeeds Credit Suisse Maintains Outperform on PG&E, Raises Price Target to $16

Credit Suisse Maintains Outperform on PG&E, Raises Price Target to $16

Credit Suisse analyst Nicholas Campanella maintains PG&E (NYSE:PCG) with a Outperform and raises the price target from $15 to $16.

byBenzinga Newsdesk

September 29, 2022

1 minute read

Credit Suisse analyst Nicholas Campanella maintains PG&E (NYSE:PCG) with a Outperform and raises the price target from $15 to $16.

RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market

By Jelena Martinovic

August 29, 10:40 AM

Cannabis-focused acquisition and investment firm RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) reported on Monday its second-quarter financial results for the three months ended on June 30, 2023.

CNPOF

Events
News

Wave Life Sciences Highlights Therapeutic Potential For WVE-006 For Alpha-1 Antitrypsin Deficiency And Progress Bringing RNA Editing To The Clinic During Analyst And Investor Event

By Benzinga Newsdesk

September 28, 1:31 PM

WVE-006 is the most advanced candidate for AATD designed to restore functional wild-type AAT protein and reduce Z-AAT protein aggregation with potential for disease modification in both lung and liver

WVE

FTX Token (FTT) Plunges 19% In 1 Hour Amid Binance’s Plan To Liquidate Entire FTX Native Token Holdings

By Mehab Qureshi

November 8, 12:38 AM

FTT (CRYPTO: FTT), the token created by crypto exchange FTX, dropped significantly amid an intensive sell-off fueled by Binance (CRYPTO: BUSD) CEO Changpeng Zhao’s annou

$BUSD

Colliers International’s High-Value Service Poised For Mid-Teens ROIC: Analyst

By Lekha Gupta

May 31, 1:00 PM

RBC Capital Markets analyst Jimmy Shan initiated coverage on Colliers International Group Inc (NASDAQ:CIGI) at Outperform at a price target of $128.…

CIGI

Credit Suisse Maintains Outperform on PG&E, Raises Price Target to $16

Related Posts

RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market

Wave Life Sciences Highlights Therapeutic Potential For WVE-006 For Alpha-1 Antitrypsin Deficiency And Progress Bringing RNA Editing To The Clinic During Analyst And Investor Event

FTX Token (FTT) Plunges 19% In 1 Hour Amid Binance’s Plan To Liquidate Entire FTX Native Token Holdings

Colliers International’s High-Value Service Poised For Mid-Teens ROIC: Analyst